Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 00:50:09 - browse：54262

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Covid misinformation case heads to Supreme Court

WSS

Burning questions for the 2024 JPM Healthcare Conference

New Ultima Genomics DNA sequencer can read genome for $100

AdventHealth escalates lawsuit against insurance vendor Multiplan

U.K. sequencing study surfaces new findings about tumor DNA

3 medical device trends to watch in 2024

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Even great ERs can’t make up for American health disparities

Bright Health sells Medicare Advantage business to Molina

Some dementia cases could be undiagnosed liver disease

Guidelines to prevent youth baseball injuries need more muscle

The FDA must approve intranasal treatments for anaphylaxis

In age of alternative facts, a scholarly course on calling out crap

General Catalyst, Summa Health deal will turn on physician buy

The high cost of giving birth even with insurance

Medicare drug price negotiation’s day in court

focus

The real point of Kenneth Smith’s execution by nitrogen gas

A $475,000 price tag for a new cancer drug: crazy or meh?

Burning questions for the 2024 JPM Healthcare Conference

Videos point to link between seizures and unexplained toddler deaths

The real point of Kenneth Smith’s execution by nitrogen gas

GSK Flovent asthma inhalers replaced by authorized generics

leisure time

hotspot

entertainment

focus